Internal Medicine

When we were kids, we were invincible—or so we thought.

ATLANTA—Serologicals Corp. announced a definitive agreement to acquire Cytomyx

PALO ALTO, Calif.—Target Discovery announced a collaboration with the Virginia Prostate Center to develop clinical assays for prostate cancer

BALTIMORE—Researchers at Johns Hopkins University (JHU), the University Würzburg, and the Institute of Bioinformatics (IOB)raised significant questions about current drug development assumptions

TEL AVIV, Israel—Compugen Ltd. announced it is leading a consortium to simulate the MAP-kinase pathway, a signaling pathway related to cancer

WEST LAFAYETTE, Ind.—BASi and the Indiana Centers for Applied Protein Sciences (INCAPS), have agreed to bring their respective contract research strengths together in a corporate alliance

BOSTON—PerkinElmer announced it acquired labeling technology from Agilix that uses isobaric mass tags for molecular quantification

HOPKINTON, Mass.—With its agreement to acquire Xenogen Corp., Caliper Life Sciences has embarked on a critical stage to truly bring together in vitro and in vivo experimentation

Project aims to streamline, shorten drug development for tuberculosis therapies

WALDBRONN, Germany—Researchers at Agilent devised a systematic approach to metabolite identification by LC/MSn that integrates automated software-aided data interpretation

GAITHERSBURG, Md.—Microdosing specialist Xceleron announced an agreement with Neurocrine Biosciences for a multi-arm Phase 0 study